Why Is Kalaris Therapeutics Stock Gaining Friday? - Kalaris Therapeutics (NASDAQ:KLRS)

Kalaris Therapeutics (NASDAQ: KLRS) stock jumps 18% after releasing expanded Phase 1a data for its AMD treatment, TH103.

Raccontata dabenzinga.com